JMPWA
RXII

JP Morgan Private Wealth Advisors’s GALENA BIOPHARMA INC COM RXII Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-130,373
Closed -$46K – 1340
2016
Q3 		$46K Hold
130,373
– – ﹤0.01% 1214
2016
Q2 		$61K Hold
130,373
– – ﹤0.01% 1228
2016
Q1 		$177K Hold
130,373
– – ﹤0.01% 1100
2015
Q4 		$192K Hold
130,373
– – ﹤0.01% 1023
2015
Q3 		$206K Hold
130,373
– – ﹤0.01% 930
2015
Q2 		$222K Hold
130,373
– – ﹤0.01% 942
2015
Q1 		$181K Hold
130,373
– – ﹤0.01% 1053
2014
Q4 		$197K Sell
130,373
-3,800
-3% -$5.74K ﹤0.01% 1005
2014
Q3 		$276K Hold
134,173
– – ﹤0.01% 869
2014
Q2 		$411K Hold
134,173
– – 0.01% 621
2014
Q1 		$335K Buy
+134,173
New +$335K 0.01% 694

JP Morgan Private Wealth Advisors's RXII Position: Q4 2016 in Review

JP Morgan Private Wealth Advisors sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 130,373 shares — an estimated $46K sold.

JP Morgan Private Wealth Advisors first reported a position in RXII in Q1 2014 and held it in 11 quarters. The position peaked at $411K in Q2 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • JP Morgan Private Wealth Advisors reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 130,373 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $46K.
  • JP Morgan Private Wealth Advisors first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 11 quarters.
  • JP Morgan Private Wealth Advisors's GALENA BIOPHARMA INC COM position peaked at $411K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.